122 related articles for article (PubMed ID: 12704670)
41. Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis.
von Knobloch R; Hegele A; Brandt H; Olbert P; Heidenreich A; Hofmann R
Int J Cancer; 2001 Oct; 94(1):67-72. PubMed ID: 11668480
[TBL] [Abstract][Full Text] [Related]
42. Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.
Pelosi G; Schianchi E; Dell'orto P; Veronesi G; Spaggiari L; Pasini F; Sozzi G; Brambilla E; Griso C; Viale G
Virchows Arch; 2006 Jan; 448(1):7-15. PubMed ID: 16193293
[TBL] [Abstract][Full Text] [Related]
43. Detection of microsatellite alterations in bronchial washings in squamous cell lung cancer: the first study from India.
Malhotra P; Behera D; Srinivasan R; Majumdar S; Wali A; Mir S; Kaur R
Jpn J Clin Oncol; 2004 Aug; 34(8):439-44. PubMed ID: 15371460
[TBL] [Abstract][Full Text] [Related]
44. Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence.
Tai AL; Yan WS; Fang Y; Xie D; Sham JS; Guan XY
Cancer; 2004 May; 100(9):1918-27. PubMed ID: 15112273
[TBL] [Abstract][Full Text] [Related]
45. Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer.
Allan JM; Hardie LJ; Briggs JA; Davidson LA; Watson JP; Pearson SB; Muers MF; Wild CP
Int J Cancer; 2001 Feb; 91(3):359-65. PubMed ID: 11169960
[TBL] [Abstract][Full Text] [Related]
46. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
47. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.
Kohno H; Hiroshima K; Toyozaki T; Fujisawa T; Ohwada H
Cancer; 1999 Jan; 85(2):341-7. PubMed ID: 10023701
[TBL] [Abstract][Full Text] [Related]
48. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
Lee HW; Seol HJ; Choi YL; Ju HJ; Joo KM; Ko YH; Lee JI; Nam DH
Int J Oncol; 2012 Dec; 41(6):2013-20. PubMed ID: 23076643
[TBL] [Abstract][Full Text] [Related]
49. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
50. Detecting lung cancer in plasma with the use of multiple genetic markers.
Andriani F; Conte D; Mastrangelo T; Leon M; Ratcliffe C; Roz L; Pelosi G; Goldstraw P; Sozzi G; Pastorino U
Int J Cancer; 2004 Jan; 108(1):91-6. PubMed ID: 14618621
[TBL] [Abstract][Full Text] [Related]
51. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
Sasatomi E; Finkelstein SD; Woods JD; Bakker A; Swalsky PA; Luketich JD; Fernando HC; Yousem SA
Cancer Res; 2002 May; 62(9):2681-9. PubMed ID: 11980668
[TBL] [Abstract][Full Text] [Related]
52. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
53. Microsatellite alterations in plasma DNA of small cell lung cancer patients.
Chen XQ; Stroun M; Magnenat JL; Nicod LP; Kurt AM; Lyautey J; Lederrey C; Anker P
Nat Med; 1996 Sep; 2(9):1033-5. PubMed ID: 8782463
[TBL] [Abstract][Full Text] [Related]
54. Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.
Shen H; Gao W; Wu YJ; Qiu HR; Shu YQ
Biomed Pharmacother; 2009 Jul; 63(6):396-403. PubMed ID: 18848758
[TBL] [Abstract][Full Text] [Related]
55. Protective effect of transferrin C3 in lung cancer?
Beckman LE; Van Landeghem GF; Sikström C; Lundgren R; Beckman L
Oncology; 1999; 56(4):328-31. PubMed ID: 10343198
[TBL] [Abstract][Full Text] [Related]
56. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
57. Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22.
Yamakawa K; Takahashi T; Horio Y; Murata Y; Takahashi E; Hibi K; Yokoyama S; Ueda R; Takahashi T; Nakamura Y
Oncogene; 1993 Feb; 8(2):327-30. PubMed ID: 8381220
[TBL] [Abstract][Full Text] [Related]
58. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung.
Yokoyama S; Yamakawa K; Tsuchiya E; Murata M; Sakiyama S; Nakamura Y
Cancer Res; 1992 Feb; 52(4):873-7. PubMed ID: 1346586
[TBL] [Abstract][Full Text] [Related]
59. Exhaled HPV infection in lung cancer: role of MA at 3p.
Carpagnano GE; Lacedonia D; Crisetti E; Palladino GP; Saliani V; Zoppo LD; Antonetti R; Natalicchio I; Foschino-Barbaro MP
Arch Med Res; 2014 Jul; 45(5):383-7. PubMed ID: 24962429
[TBL] [Abstract][Full Text] [Related]
60. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
Erbersdobler A; Friedrich MG; Schwaibold H; Henke RP; Huland H
Oncol Res; 1998; 10(8):415-20. PubMed ID: 10100758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
